Search

everythinglearnresearchcommunity

for

Search:↓

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

No cure for female pattern hair loss, but various effective treatments exist.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Estrogen therapy can reduce skin aging but has cancer risks.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.